TMUNITY THERAPEUTICS
Startup
TMUNITY THERAPEUTICS
Description
Tmunity Therapeutics developsT-cell immunotherapy for cancer, infectious disease and autoimmune disease. Its pipeline includes investigational next-generation therapies for a range of cancers including prostate, myeloma, melanoma and synovial sarcoma.
TMUNITY THERAPEUTICS
Address
United States
Contact
Description
Tmunity Therapeutics developsT-cell immunotherapy for cancer, infectious disease and autoimmune disease. Its pipeline includes investigational next-generation therapies for a range of cancers including prostate, myeloma, melanoma and synovial sarcoma.
Matchmaking
Connect with TMUNITY THERAPEUTICS
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways